Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank79
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-2.04%
↑ 94% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-34.22%
Historical baseline
PeriodValue
2025-2.04%
202414.17%
2023-15.46%
2022-16.39%
2021-30.83%
2020-26.62%
2019-61.29%
2018-38.09%
2017-73.15%
2016-92.53%